Use of subcutaneous immunoglobulin in primary immune deficiencies


Creative Commons License

AYDINER E. , Kiykim A., BARIŞ S. , Ozen A. O. , Barlan I.

TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS, vol.51, no.1, pp.8-14, 2016 (Journal Indexed in ESCI) identifier identifier

  • Publication Type: Article / Review
  • Volume: 51 Issue: 1
  • Publication Date: 2016
  • Doi Number: 10.5152/turkpediatriars.2016.3058
  • Title of Journal : TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS
  • Page Numbers: pp.8-14

Abstract

Aim: Immunoglobulin replacement therapy is required to reduce the frequency and severity of infections in patients with primary antibody deficiencies. Immunoglobulin G (IgG) can be administered intramuscularly, intravenously or subcutaneously. We aimed to evaluate the efficacy, dose adjustment and adverse events in subcutaneous immunoglobulin therapy by retrospectively presenting the records of 16 patients who received subcutaneous immunoglobulin therapy.